Essentials in Candida bloodstream infection
- PMID: 30218311
- DOI: 10.1007/s15010-018-1218-1
Essentials in Candida bloodstream infection
Abstract
Aims: Due to the increase of severely immunocompromised patients, of invasive procedures including central intravascular catheters, and of the use of broad-spectrum antibiotics, the incidence of Candida bloodstream infections has risen intensely in the last decades. Candida bloodstream infection is a serious disease with high mortality. Optimized diagnostic and therapeutic management can improve outcome. Thus, the aim of our mini-review is to highlight important and often missed opportunities in the management of Candida bloodstream infection.
Methods: We searched the published literature and describe the essentials in the management of Candida bloodstream infection.
Results: Four essentials were identified: (1) isolation of Candida spp. from a blood culture should always be considered relevant and requires treatment. Daily blood cultures should be drawn to determine cessation of candidemia. (2) Central venous catheter (CVC) and/or other indwelling devices should be removed. (3) Echinocandins are the first choice. Antifungal treatment should be continued for at least 14 days after cessation of fungemia. Susceptibility testing should be performed to identify resistance and to facilitate transition to oral treatment. (4) In persistent candidemia, echocardiography is an important investigation; ophthalmoscopy should be considered.
Conclusion: Further efforts should be undertaken to increase the adherence to the essentials in the management of Candia bloodstream infection.
Similar articles
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.Cancer. 2004 Dec 15;101(12):2859-65. doi: 10.1002/cncr.20710. Cancer. 2004. PMID: 15529309
-
[Bloodstream Candida infections].Antibiot Khimioter. 2007;52(4-5):30-42. Antibiot Khimioter. 2007. PMID: 18464563 Review. Russian.
-
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.Bone Marrow Transplant. 2001 Nov;28(9):873-8. doi: 10.1038/sj.bmt.1703252. Bone Marrow Transplant. 2001. PMID: 11781648
-
A single center's experience with Candida parapsilosis related long-term central venous access device infections: the port removal decision and its outcomes.Pediatr Hematol Oncol. 2014 Aug;31(5):435-41. doi: 10.3109/08880018.2013.862587. Epub 2014 Jan 2. Pediatr Hematol Oncol. 2014. PMID: 24383767 Clinical Trial.
Cited by
-
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens.Int Microbiol. 2021 Jan;24(1):57-63. doi: 10.1007/s10123-020-00141-1. Epub 2020 Aug 9. Int Microbiol. 2021. PMID: 32772220 Free PMC article.
-
Shorter time-to-positivity and turnaround time with mycosis blood culture bottles when detecting Candida albicans.Infection. 2024 Apr;52(2):701-703. doi: 10.1007/s15010-024-02216-x. Epub 2024 Feb 23. Infection. 2024. PMID: 38393640 Free PMC article. No abstract available.
-
Multilocus sequence typing (MLST) analysis reveals many novel genotypes and a high level of genetic diversity in Candida tropicalis isolates from Italy and Africa.Mycoses. 2022 Nov;65(11):989-1000. doi: 10.1111/myc.13483. Epub 2022 Jul 7. Mycoses. 2022. PMID: 35713604 Free PMC article.
-
Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM.J Fungi (Basel). 2021 May 1;7(5):356. doi: 10.3390/jof7050356. J Fungi (Basel). 2021. PMID: 34062848 Free PMC article.
-
A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.Antimicrob Resist Infect Control. 2020 Aug 14;9(1):133. doi: 10.1186/s13756-020-00798-3. Antimicrob Resist Infect Control. 2020. PMID: 32799915 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous